Humana (HUM) → Stock, financial statements
Advertising

Humana: stocks, financial statements

Dividends News
Favorites

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty, Healthcare Services, and Individual Commercial. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans such as Medicare, and State-based Medicaid contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance benefits. The Healthcare Services segment offer services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics services to other Humana businesses, as well as external health plan members, external health plans, and other employers.. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand. The company was founded by David A. Jones, Sr. and Wendell Cherry in 1961 and is headquartered in Louisville, KY.

  • HUM Ticker
  • 🇺🇸 NYSE Exchange
  • 43,600 Employees
5 rated
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon

Financial statements — Humana

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
77B 65B 57B 54B 54B
Cost Of Revenue
0 0 0 0 0
Gross Profit
77B 65B 57B 54B 54B
Research and Development
0 0 0 0 0
Selling General and Admin
0 0 0 0 0
Operating Expense
72B 62B 54B 50B 53B
Operating Income
5B 3.2B 3.1B 3.3B 1.7B
Other Income Expense Net
0 0 0 0 0
EBIT
5.1B 3.2B 3.1B 3.3B 1.7B
Interest Income
280M 240M 220M 240M 190M
Pretax Income
4.7B 3.5B 2.1B 4B 1.6B
Income Tax
1.3B 760M 390M 1.6B 940M
Minority Interest
0 0 0 0 0
Net Income
3.4B 2.7B 1.7B 2.4B 610M
Net Income Basic
3.4B 2.7B 1.7B 2.4B 610M
20 ← 16 2020 2019 2018 2017 2016
Current cash
0 0 0 0 0
Short term investments
18B 15B 14B 13B 11B
Receivables
1.1B 1.1B 1B 850M 1.3B
Inventory
0 0 0 0 0
Other current assets
5.3B 3.8B 3.6B 2.9B 3.4B
Current assets
24B 20B 17B 17B 16B
Long term investments
11B 9.2B 8.5B 9.8B 9.2B
Property plant equipment
2.4B 2B 1.7B 1.6B 1.5B
Goodwill
4.4B 3.9B 3.9B 3.3B 3.3B
Intangible assets
0 0 0 0 0
Other assets
3.3B 2.2B 1.8B 4.9B 4.4B
Total assets
35B 29B 25B 27B 25B
Accounts payable
0 0 0 0 0
Current long term debt
920M 920M 1.9B 290M 510M
Other current liabilities
12B 10B 8.2B 9.1B 7.3B
Total current liabilities
13B 11B 10B 9.4B 7.8B
Long term debt
6.1B 5B 4.4B 4.8B 3.8B
Other liabilities
1.8B 1.1B 800M 3.2B 3.1B
Minority Interest
0 0 0 0 0
Total Liabilities
21B 17B 15B 17B 15B
Common stock
130M 130M 140M 140M 150M
Retained earning
21B 17B 15B 14B 11B
Treasury stock
-9.9B -8.5B -7.3B -6.3B -3.3B
Capital surplus
Shareholder equity
14B 12B 10B 9.8B 11B
Net tangible assets
9.3B 8.1B 6.3B 6.6B 7.4B
20 ← 16 2020 2019 2018 2017 2016
Net Income
3.4B 2.7B 1.7B 2.4B 610M
Depreciation
620M 580M 530M 490M 470M
Changes in receivables
82M 41M 160M -430M 120M
Changes in inventories
0 0 0 0 0
Cash change
620M 1.7B -1.7B 170M 1.3B
Cash flow
5.6B 5.3B 2.2B 4.1B 1.9B
Capital expenditures
-960M -740M -610M -530M -530M
Investments
Investing activity other
Total investing cash flows
-3.1B -1.3B -3.1B -2.9B -1.4B
Dividends paid
320M
Net borrowings
-11B -8.9B -7.4B -7.4B -6.7B
Other financing cash flows
Cash flow financing
-2B -2.3B -790M -950M 730M
Exchange rate effect